IP Library Granted Patent US 10,030,260
Granted Patent B2
US 10,030,260 · App. 14/436,139 · Granted Jul 24, 2018

Inducible reconstitution and real-time quantitative kinetic system for the study of intramembrane enzymes

Inventors: Sinisa Urban (Baltimore, MD); Rosanna Baker (Baltimore, MD); Seth Dickey (Baltimore, MD)
Assignee: The Johns Hopkins University
C12Q1/37G01N33/573G01N2333/952G01N2500/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,030,260
App. No.
14/436,139
Granted
Jul 24, 2018
Kind
B2
Abstract

The present invention relates to the field of enzymes. More specifically, the present invention provides an inducible reconstitution and real-time quantitative kinetic system for the study of intramembrane enzymes. In a specific embodiment, a method of screening for modulators of an intramembrane protease comprises the steps of (a) contacting in a mixture the protease and a substrate with a lipid under acidic or basic conditions to form a membrane comprising the lipid bilayer, protease and the substrate; (b) contacting a test agent with the membrane mixture; (c) adjusting the pH to physiological conditions; (d) assaying substrate cleavage by the protease; and (e) comparing the assayed substrate cleavage to a reference that does not include the test agent, wherein an increase or a decrease of substrate cleavage by the protease relative to the reference identifies the test agent as a modulator of the intramembrane protease.

Claims (38)

1. A method of screening for modulators of an intramembrane protease comprising the steps of:

a. contacting in a mixture the protease and a substrate with a lipid under acidic or basic conditions to (i) form a membrane comprising the lipid bilayer, protease and the substrate and (ii) render the protease catalytically inactive;

b. contacting a test agent with the membrane mixture;

c. adjusting the pH to physiological conditions to render the protease catalytically active;

d. assaying substrate cleavage by the protease; and

e. comparing the assayed substrate cleavage to a reference that does not include the test agent, wherein an increase or a decrease of substrate cleavage by the protease relative to the reference identifies the test agent as a modulator of the intramembrane protease.

2. The method of claim 1 , wherein the intramembrane protease is a rhomboid protease.

3. The method of claim 1 , wherein the intramembrane protease is a γ-secretase.

4. The method of claim 1 , wherein the intramembrane protease is a site-2 protease.

5. The method of claim 1 , wherein the intramembrane protease is a presenilin homolog, prepilin peptidase, preflagellin peptidase or signal peptide peptidase.

6. The method of claim 1 , wherein acidic conditions comprise about pH 3 to about pH 5.

7. The method of claim 1 , wherein acidic conditions comprise about pH 4.

8. The method of claim 1 , wherein acidic conditions comprise pH 4.

9. The method of claim 1 , wherein physiological conditions comprise about pH 7.4.

10. The method of claim 1 , wherein physiological conditions comprise pH 7.4.

11. The method of claim 1 , wherein the substrate comprises a detectable label.

12. The method of claim 11 , wherein the detectable label is conjugated to the amino terminus of the substrate.

13. The method of claim 11 , wherein the detectable label is conjugated to the carboxy terminus of the substrate.

14. The method of claim 11 , wherein the detectable label is conjugated to the extracellular or intracellular domain of the substrate.

15. The method of claim 11 , wherein the detectable label is a modified side chain at any internal position of the substrate.

16. A method of screening for modulators of an intramembrane rhomboid protease comprising the steps of:

a. contacting in a mixture the protease and a substrate with a lipid at pH 4.0 to (i) form a membrane comprising the lipid bilayer, protease and the substrate and (ii) render the protease catalytically inactive;

b. contacting a test agent with the membrane mixture;

c. raising the pH to pH 7.4 to render the protease catalytically active;

d. assaying substrate cleavage by the protease; and

e. comparing the assayed substrate cleavage to a reference that does not include the test agent, wherein an increase or a decrease of substrate cleavage by the protease relative to the reference identifies the test agent as a modulator of the intramembrane protease.

17. A method for identifying inhibitors of an intramembrane rhomboid protease comprising the steps of:

a. contacting in a mixture the protease and a substrate with a lipid at pH 4.0 to (i) form a membrane comprising the lipid bilayer, protease and the substrate and (ii) render the protease catalytically inactive;

b. contacting a test agent with the membrane mixture;

c. raising the pH to pH 7.4 to render the protease catalytically active;

d. assaying substrate cleavage by the protease; and

e. comparing the assayed substrate cleavage to a reference that does not include the test agent, wherein a decrease of substrate cleavage by the protease relative to the reference identifies the test agent as an inhibitor of the intramembrane rhomboid protease.

18. A method for identifying agonists of an intramembrane rhomboid protease comprising the steps of:

a. contacting the protease and a substrate with a lipid at pH 4.0 to (i) form a membrane comprising the lipid bilayer, protease and the substrate and (ii) render the protease catalytically inactive;

b. contacting a test agent with the membrane mixture;

c. raising the pH to pH 7.4 to render the protease catalytically active;

d. assaying substrate cleavage by the protease; and

e. comparing the assayed substrate cleavage to a reference that does not include the test agent, wherein an increase of substrate cleavage by the protease relative to the reference identifies the test agent as an agonist of the intramembrane rhomboid protease.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2018
From: URBAN, SINISA; BAKER, ROSANNA; DICKEY, SETH
To: THE JOHNS HOPKINS UNIVERSITY
Reel/Frame 044965/0340 →
CONFIRMATORY LICENSE Recorded Jun 27, 2016
From: JOHNS HOPKINS UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 039172/0980 →
Continuity (2)
Provisional Application 61714417 · Oct 16, 2012
Related Publication 20150267243A1 · Sep 24, 2015